Morgan Stanley Enanta Pharmaceuticals Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Morgan Stanley holds 1,102,852 shares of ENTA stock, worth $6.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,102,852

Previous 1,456,559 24.28%

Holding current value

$6.96 Million

Previous $18.9 Million 39.46%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.05 - $16.54 $3.55 Million - $5.85 Million	-353,707 Reduced 24.28%	1,102,852 $11.4 Million
Q2 2024 Oct 17, 2024	SELL	$11.43 - $17.02 $6.73 Million - $10 Million	-588,586 Reduced 28.78%	1,456,559 $18.9 Million
Q2 2024 Aug 14, 2024	SELL	$11.43 - $17.02 $6.73 Million - $10 Million	-588,586 Reduced 28.78%	1,456,559 $18.9 Million
Q1 2024 Oct 17, 2024	BUY	$10.08 - $17.46 $5.93 Million - $10.3 Million	588,586 Added 40.41%	2,045,145 $35.7 Million
Q1 2024 Aug 16, 2024	BUY	$10.08 - $17.46 $8.79 Million - $15.2 Million	872,087 Added 74.34%	2,045,145 $35.7 Million
Q1 2024 May 15, 2024	BUY	$10.08 - $17.46 $8.79 Million - $15.2 Million	872,087 Added 74.34%	2,045,145 $35.7 Million
Q4 2023 Aug 16, 2024	SELL	$8.18 - $10.78 $2.32 Million - $3.06 Million	-283,501 Reduced 19.46%	1,173,058 $11 Million
Q4 2023 Feb 13, 2024	BUY	$8.18 - $10.78 $4.98 Million - $6.56 Million	608,492 Added 107.78%	1,173,058 $11 Million
Q3 2023 Nov 15, 2023	BUY	$11.09 - $22.13 $2.85 Million - $5.69 Million	257,264 Added 83.72%	564,566 $6.31 Million
Q2 2023 Aug 14, 2023	BUY	$20.68 - $39.85 $3.63 Million - $6.99 Million	175,354 Added 132.9%	307,302 $6.58 Million
Q1 2023 May 15, 2023	SELL	$38.82 - $54.59 $255,319 - $359,038	-6,577 Reduced 4.75%	131,948 $5.34 Million
Q4 2022 Feb 14, 2023	SELL	$40.77 - $53.73 $1.76 Million - $2.32 Million	-43,149 Reduced 23.75%	138,525 $6.44 Million
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $3.05 Million - $4.5 Million	-63,200 Reduced 25.81%	181,674 $9.42 Million
Q2 2022 Oct 27, 2022	BUY	$38.13 - $76.93 $2.99 Million - $6.03 Million	78,326 Added 47.03%	244,874 $11.6 Million
Q2 2022 Aug 15, 2022	BUY	$38.13 - $76.93 $2.99 Million - $6.03 Million	78,326 Added 47.03%	244,874 $11.6 Million
Q1 2022 Oct 27, 2022	SELL	$56.06 - $74.11 $4.39 Million - $5.8 Million	-78,326 Reduced 31.99%	166,548 $11.9 Million
Q1 2022 May 13, 2022	BUY	$56.06 - $74.11 $2.27 Million - $3 Million	40,479 Added 32.11%	166,548 $11.9 Million
Q4 2021 Feb 14, 2022	SELL	$60.19 - $97.37 $2.18 Million - $3.52 Million	-36,163 Reduced 22.29%	126,069 $9.43 Million
Q3 2021 Nov 15, 2021	BUY	$41.02 - $58.65 $6.65 Million - $9.51 Million	162,232 New	162,232 $9.22 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $131M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account